跳至主要内容
临床试验/JPRN-UMIN000021695
JPRN-UMIN000021695已完成未知

PREVENTion of Contrast-Induced Nephropathy after Cardiovascular catheterization and intervention by high dose statin therapy in Japan - PREVENTion of Contrast-Induced Nephropathy after Cardiovascular catheterization and intervention by high dose statin therapy in Japan (Prevent CINC-J study)

ara Medical University0 个研究点目标入组 420 人开始时间: 2016年5月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Contraindication to statin treatment 2. Contraindication to contrast medium 3. Treatment with fibrate 4. Treatment with cyclosporine 5. Severe liver dysfunction (acute hepatitis, liver cirrhosis, liver cancer, jaundice, GOT or GPT>=100IU/l) 6. Severe renal dysfunction (acute renal failure, maintenance dialysis, serum creatinine>=3mg/dl) 7. CPK>=350IU/L 8. Patients receiving high dose statin (atorvastatine;>=15mg/day,rosvastatin;>=7.5mg/day,pitavastatin;>=3mg/day) before enrollment 9. Familial hypercholesterolemia 10. Nephrotic syndrome 11. Contrast medium administration within the previous 10 days 12. Pregnant, becoming pregnant, breast feeding 13. Inadequate to this study

研究者

发起方
ara Medical University

相似试验

PREVENTion of Contrast-Induced Nephropathy after... | 临床试验